SCHEMBL13247876

SCHEMBL13247876

CCCCCn1c(=O)n(CCCn2c3ccccc3c3ccccc32)c(=O)c2[nH]c(Cl)nc21

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.50
▸ RORA P35398 1/20 0.50
▸ RORC P51449 1/20 0.50
▸ RORB Q92753 1/20 0.50
▸ ADORA2B P29275 4/20 0.48
▸ ADORA2A P29274 3/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ ADORA1 P30542 2/20 0.47
▸ CNR2 P34972 3/20 0.46
▸ GAA P10253 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13247866 0.88 ADORA2B (0.48) ADORA2BADORA2AKDM4EALDH1A1HSD17B10
SCHEMBL13247888 0.86 RAB9A (0.48) PGRADORA2BADORA2AKDM4EALDH1A1
SCHEMBL14619221 0.86 ADORA2B (0.44) ADORA2BADORA2AKDM4EALDH1A1HSD17B10
SCHEMBL13247879 0.84 ADORA2A (0.42) ADORA2BADORA2AKDM4EALDH1A1HSD17B10
SCHEMBL3105542 0.84 ADORA1 (0.49) ADORA2BADORA2AKDM4EALDH1A1HSD17B10
SCHEMBL3115718 0.83 ADORA2A (0.55) ADORA2BADORA2AKDM4EALDH1A1HSD17B10
SCHEMBL3119443 0.83 SIRT1 (0.54) ADORA2BADORA2AADORA1
SCHEMBL13247861 0.83 ADORA2B (0.45) ADORA2BADORA2AKDM4EALDH1A1HSD17B10
SCHEMBL3105805 0.83 ADORA2B (0.45) ADORA2BADORA2AKDM4EALDH1A1HSD17B10
SCHEMBL3115617 0.83 ALDH1A1 (0.48) ADORA2BADORA2AKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 — — US disclosed
WO-2007017262-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2007-02-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 PGR 1888/4885RORA 146/4885RORC 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback